NCT01228617View on ClinicalTrials.gov

Single-dose Pharmacokinetics of Oral Nicotine Replacement Products

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Tobacco Dependence
Interventions
DRUG

Nicotine

Following a 12-hour nicotine abstinence period, subjects receive a single 2 mg dose of their assigned nicotine replacement therapy in the morning of the treatment visit day

DRUG

Nicotine Gum

Following a 12-hour nicotine abstinence period, subjects will be instructed to chew the gum once every 2 seconds, for 30 minutes.

Trial Locations (1)

SE-221 85

Clinical Trial Unit, Clinical Research and Trial Centre, Lund

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT01228617 - Single-dose Pharmacokinetics of Oral Nicotine Replacement Products | Biotech Hunter | Biotech Hunter